GB1382487A - Substituted pyrido-3,2-d-pyrimidines - Google Patents
Substituted pyrido-3,2-d-pyrimidinesInfo
- Publication number
- GB1382487A GB1382487A GB1621272A GB1621272A GB1382487A GB 1382487 A GB1382487 A GB 1382487A GB 1621272 A GB1621272 A GB 1621272A GB 1621272 A GB1621272 A GB 1621272A GB 1382487 A GB1382487 A GB 1382487A
- Authority
- GB
- United Kingdom
- Prior art keywords
- group
- compounds
- chloro
- amino
- thiol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 3
- -1 morpholino, thiomorpholino, 1-oxidothiomorpholino, 1,1 -dioxidothiomorpholino Chemical group 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 150000003573 thiols Chemical class 0.000 abstract 2
- NDOVLWQBFFJETK-UHFFFAOYSA-N 1,4-thiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCC1 NDOVLWQBFFJETK-UHFFFAOYSA-N 0.000 abstract 1
- INUSQTPGSHFGHM-UHFFFAOYSA-N 2,4-dichloro-5-nitropyrimidine Chemical compound [O-][N+](=O)C1=CN=C(Cl)N=C1Cl INUSQTPGSHFGHM-UHFFFAOYSA-N 0.000 abstract 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229930194542 Keto Natural products 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000005122 aminoalkylamino group Chemical group 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- MLUCVPSAIODCQM-NSCUHMNNSA-N crotonaldehyde Chemical compound C\C=C\C=O MLUCVPSAIODCQM-NSCUHMNNSA-N 0.000 abstract 1
- MLUCVPSAIODCQM-UHFFFAOYSA-N crotonaldehyde Natural products CC=CC=O MLUCVPSAIODCQM-UHFFFAOYSA-N 0.000 abstract 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000008518 pyridopyrimidines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical group C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712117657 DE2117657B2 (de) | 1971-04-10 | 1971-04-10 | Pyrido eckige klammer auf 3,2- d eckige klammer zu pyrimidine |
| DE19722202367 DE2202367A1 (de) | 1972-01-19 | 1972-01-19 | Neues verfahren zur herstellung von pyrido eckige klammer auf 3,2-d eckige klammer zu pyrimidinen |
| DE19722208535 DE2208535A1 (de) | 1972-02-23 | 1972-02-23 | Neue pyrido eckige klammer auf 3,2-d eckige klammer zu pyrimidine |
| DE19722208534 DE2208534A1 (de) | 1972-02-23 | 1972-02-23 | Neue pyrido eckige klammer auf 3,2-d eckige klammer zu pyrimidin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1382487A true GB1382487A (en) | 1975-02-05 |
Family
ID=27431239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1621272A Expired GB1382487A (en) | 1971-04-10 | 1972-04-07 | Substituted pyrido-3,2-d-pyrimidines |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE781900A (en:Method) |
| CA (1) | CA992081A (en:Method) |
| DD (1) | DD97204A5 (en:Method) |
| GB (1) | GB1382487A (en:Method) |
| HU (1) | HU164346B (en:Method) |
| IE (1) | IE36269B1 (en:Method) |
| IL (1) | IL39174A (en:Method) |
| NL (1) | NL7204783A (en:Method) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0404355A1 (en) * | 1989-05-30 | 1990-12-27 | Smithkline Beecham Intercredit B.V. | Pyridopyrimidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
-
1972
- 1972-04-07 GB GB1621272A patent/GB1382487A/en not_active Expired
- 1972-04-07 DD DD162145A patent/DD97204A5/xx unknown
- 1972-04-07 CA CA139,149A patent/CA992081A/en not_active Expired
- 1972-04-10 HU HUTO872A patent/HU164346B/hu unknown
- 1972-04-10 BE BE781900A patent/BE781900A/xx unknown
- 1972-04-10 IL IL39174A patent/IL39174A/xx unknown
- 1972-04-10 IE IE461/72A patent/IE36269B1/xx unknown
- 1972-04-10 NL NL7204783A patent/NL7204783A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0404355A1 (en) * | 1989-05-30 | 1990-12-27 | Smithkline Beecham Intercredit B.V. | Pyridopyrimidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
Also Published As
| Publication number | Publication date |
|---|---|
| IE36269B1 (en) | 1976-09-29 |
| DD97204A5 (en:Method) | 1973-04-20 |
| IL39174A (en) | 1975-02-10 |
| BE781900A (fr) | 1972-10-10 |
| IE36269L (en) | 1972-10-10 |
| CA992081A (en) | 1976-06-29 |
| NL7204783A (en:Method) | 1972-10-12 |
| IL39174A0 (en) | 1972-06-28 |
| HU164346B (en:Method) | 1974-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1449100A (en) | Pyrimidine derivatives processes for their preparation and their use in pharmaceutical compositions | |
| GEP19960242B (en) | Method for Production of Derivatives of Benzohydrilsulfinyl or its Salts | |
| GB1376096A (en) | 1-3,4-methylenedioxy-phenyl-4,4-dimethyl-1-pentene derivatives | |
| GB1457279A (en) | Beta-amino carbonyl derivatives of morpholine and piperazine | |
| GB1506914A (en) | 2-dihalophenylamino-2-imidazoline derivatives | |
| GB1369248A (en) | Amides the preparation thereof and their use in pharmacjeutical compositions | |
| GB1382487A (en) | Substituted pyrido-3,2-d-pyrimidines | |
| GB1432660A (en) | Piperazine derivatives processes for their preparation and and pharamacueitcal compositions containing them | |
| GB1409648A (en) | Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof | |
| GB1225462A (en:Method) | ||
| GB1390658A (en) | Thiazolopyrimidine derivatives | |
| GB1399470A (en) | Derivatives of pyrazolopyridine ketones | |
| GB1369294A (en) | Purine-ribofuranoside-2,5,-cyclophosphates | |
| GB1508737A (en) | Carbostyril derivatives and their use as coccidiostats | |
| GB1425049A (en) | Substituted 2-hydroxy-2-phenylethyl-amines | |
| GB1244880A (en) | Ergolene derivatives | |
| GB1207116A (en) | Morphanthridine derivatives | |
| GB1417355A (en) | Substituted piperazine and homopiperazine derivatives | |
| DE3580888D1 (de) | 2-aminothiazolderivate die eine saeureausscheidungshemmende wirkung besitzen. | |
| GB1374326A (en) | Amino acids | |
| GB1343916A (en) | Compounds of the azaspirane series | |
| GB1410303A (en) | Piperazinyl-butanol derivatives | |
| GB1414589A (en) | Yohimbohydrazide derivatives process for their preparation and their applications | |
| IE35148B1 (en) | Piperazides and processes for their manufacture | |
| GB1432904A (en) | N-2-n-cyclohexyl-n-methylaminomethyl-4,6-dibromo-phenyl-benzamides methods for their preparation and compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |